David Protein was last valued at $725M. It comes from the $75M Series A of May 2025. The company is private, so there is no listed share price.
1 valuation. The latest, $725M post-money, was set by the Series A in May 2025.
A private valuation is the price agreed in one transaction. The David Protein valuation of $725M is a private-market figure from the Series A dated 29 May 2025 — the whole company measured after the $75M raised in that round was already inside it. Subtract the round and the pre-money view of the same deal is $650M .
The valuation holds until the next priced round or secondary sale. A private company founded in 2023 with roughly 285 people has no daily price and no order book between rounds.
No. David Protein is a private company; its shares do not trade on a public exchange.
The last valuation is $725M.
Lead investors for each round are in the funding timeline.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
